Barclays PLC
7 June 2001
7 June 2001
Notification of directors' interests: Companies Act 1985 s.329
The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust,
(the 'ESAS trust') notified the company on 6 June 2001 that it had on 5 June
2001 exercised its discretion and released 1,049 ordinary shares in Barclays
PLC to a participant in the Executive Share Award Scheme ('ESAS').
The ESAS trust is a discretionary trust for the benefit of employees and
former employees (and their families) of Barclays Bank PLC and its
subsidiaries.
None of these shares were transferred to a Director of Barclays PLC.
Following this transaction, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 9,497,279 ordinary shares in Barclays PLC. Sir
Peter Middleton, Mr M W Barrett, Sir Andrew Large, Mr C J Lendrum, Mr J M
Stewart and Mr J S Varley, Directors of Barclays PLC, are amongst the
potential beneficiaries under these trusts and are therefore regarded for
Companies Act purposes as being interested in the Barclays PLC ordinary shares
held in them.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.